{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:32:38Z","timestamp":1786120358092,"version":"build-2736575974"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1097\/sla.0b013e318234313b","type":"journal-article","created":{"date-parts":[[2011,10,13]],"date-time":"2011-10-13T05:16:18Z","timestamp":1318482978000},"page":"399-404","source":"Crossref","is-referenced-by-count":58,"title":["Preoperative Aspirin Use and Outcomes in Cardiac Surgery Patients"],"prefix":"10.1097","volume":"255","author":[{"given":"Longhui","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilas","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Silvestry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Will","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Diehl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianzhong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-31-20210203","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high-risk patients.","volume":"324","year":"2002","journal-title":"BMJ"},{"key":"R2-31-20210203","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.amjmed.2007.10.002","article-title":"Low-dose aspirin in patients with stable cardiovascular disease: a meta-analysis.","volume":"121","author":"Becker","year":"2008","journal-title":"Am J Med"},{"key":"R3-31-20210203","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/01.CIR.101.10.1206","article-title":"Aspirin.","volume":"101","author":"Awtry","year":"2000","journal-title":"Circulation"},{"key":"R4-31-20210203","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1001\/jama.292.15.1867","article-title":"Oral antiplatelet therapy in cerebrovascular disease, coronary artery disease, and peripheral arterial disease.","volume":"292","author":"Tran","year":"2004","journal-title":"JAMA"},{"key":"R5-31-20210203","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1056\/NEJM198207083070201","article-title":"A platelet-inhibitor-drug trial in coronary-artery bypass operations: benefit of perioperative dipyridamole and aspirin therapy on early postoperative vein-graft patency.","volume":"307","author":"Chesebro","year":"1982","journal-title":"N Engl J Med"},{"key":"R6-31-20210203","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1161\/01.CIR.80.5.1190","article-title":"Saphenous vein graft patency 1 year after coronary artery bypass surgery and effects of antiplatelet therapy. Results of a Veterans Administration Cooperative Study.","volume":"80","author":"Goldman","year":"1989","journal-title":"Circulation"},{"key":"R7-31-20210203","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.ahj.2010.07.035","article-title":"Randomized trial of aspirin and clopidogrel versus aspirin alone for the prevention of coronary artery bypass graft occlusion: the Preoperative Aspirin and Postoperative Antiplatelets in Coronary Artery Bypass Grafting study.","volume":"160","author":"Sun","year":"2010","journal-title":"Am Heart J"},{"key":"R8-31-20210203","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1161\/CIRCULATIONAHA.110.978007","article-title":"Aspirin plus clopidogrel versus aspirin alone after coronary artery bypass grafting: the clopidogrel after surgery for coronary artery disease (CASCADE) Trial.","volume":"122","author":"Kulik","year":"2010","journal-title":"Circulation"},{"key":"R9-31-20210203","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa020798","article-title":"Multicenter Study of Perioperative Ischemia Research Group. Aspirin and mortality from coronary bypass surgery.","volume":"347","author":"Mangano","year":"2002","journal-title":"N Engl J Med"},{"key":"R10-31-20210203","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/j.jtcvs.2009.07.027","article-title":"Aspirin and clopidogrel use in the early postoperative period following on-pump and off-pump coronary artery bypass grafting.","volume":"138","author":"Kim","year":"2009","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R11-31-20210203","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1016\/S0003-4975(00)02133-0","article-title":"Effect of preoperative aspirin use on mortality in coronary artery bypass grafting patients.","volume":"70","author":"Dacey","year":"2000","journal-title":"Ann Thorac Surg"},{"key":"R12-31-20210203","doi-asserted-by":"crossref","first-page":"I286","DOI":"10.1161\/CIRCULATIONAHA.104.522805","article-title":"Preoperative aspirin therapy is associated with improved postoperative outcomes in patients undergoing coronary artery bypass grafting.","volume":"112","author":"Bybee","year":"2005","journal-title":"Circulation"},{"key":"R13-31-20210203","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1161\/CIRCULATIONAHA.110.957373","article-title":"Effect of timing of chronic preoperative aspirin discontinuation on morbidity and mortality in coronary artery bypass surgery.","volume":"123","author":"Jacob","year":"2011","journal-title":"Circulation"},{"key":"R14-31-20210203","doi-asserted-by":"crossref","first-page":"44C","DOI":"10.1016\/j.amjcard.2009.06.015","article-title":"Platelet-directed therapies and coronary artery bypass grafting.","volume":"104","author":"Berger","year":"2009","journal-title":"Am J Cardiol"},{"key":"R15-31-20210203","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1093\/eurheartj\/ehn104","article-title":"The effect of pre-operative aspirin on bleeding, transfusion, myocardial infarction, and mortality in coronary artery bypass surgery: a systematic review of randomized and observational studies.","volume":"29","author":"Sun","year":"2008","journal-title":"Eur Heart J"},{"key":"R16-31-20210203","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1517\/14740330902797081","article-title":"Antiplatelet therapy and coronary artery bypass graft surgery: perioperative safety and efficacy.","volume":"8","author":"Kulik","year":"2009","journal-title":"Expert Opin Drug Saf"},{"key":"R17-31-20210203","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1161\/01.CIR.0000138790.14877.7D","article-title":"ACCAHA 2004 guideline update for coronary artery bypass graft surgery: summary article: a report of the American College of CardiologyAmerican Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery).","volume":"110","author":"Eagle","year":"2004","journal-title":"Circulation"},{"key":"R18-31-20210203","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.athoracsur.2005.01.008","article-title":"The society of thoracic surgeons practice guideline series: aspirin and other antiplatelet agents during operative coronary revascularization (executive summary).","volume":"79","author":"Ferraris","year":"2005","journal-title":"Ann Thorac Surg"},{"key":"R19-31-20210203","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ejcts.2008.02.024","article-title":"Guideline on antiplatelet and anticoagulation management in cardiac surgery.","volume":"34","author":"Dunning","year":"2008","journal-title":"Eur J Cardiothorac Surg"},{"key":"R20-31-20210203","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1001\/jama.287.17.2221","article-title":"Preoperative beta-blocker use and mortality and morbidity following CABG surgery in North America.","volume":"287","author":"Ferguson","year":"2002","journal-title":"JAMA"},{"key":"R21-31-20210203","doi-asserted-by":"crossref","first-page":"e63","DOI":"10.1016\/j.jss.2009.11.702","article-title":"Preoperative renin-angiotensin system inhibitors protect renal function in aging patients undergoing cardiac surgery.","volume":"167","author":"Barodka","year":"2011","journal-title":"J Surg Res"},{"key":"R22-31-20210203","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1161\/CIRCULATIONAHA.105.594952","article-title":"Propensity scores in cardiovascular research.","volume":"115","author":"DAgostino","year":"2007","journal-title":"Circulation"},{"key":"R23-31-20210203","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0049-3848(03)00379-7","article-title":"The mechanism of action of aspirin.","volume":"110","author":"Vane","year":"2003","journal-title":"Thromb Res"},{"key":"R24-31-20210203","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0140-6736(97)04011-7","article-title":"IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischemic stroke. International Stroke Trial Collaborative Group.","volume":"349","year":"1997","journal-title":"Lancet"},{"key":"R25-31-20210203","first-page":"349","article-title":"Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group.","volume":"2","year":"1988","journal-title":"Lancet"},{"key":"R26-31-20210203","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1161\/CIRCULATIONAHA.107.188208","article-title":"2007 Focused Update of the ACCAHASCAI 2005 Guideline Update for Percutaneous Coronary Intervention: a report of the American College of CardiologyAmerican Heart Association Task Force on Practice Guidelines: 2007 Writing Group to Review New Evidence and Update the ACCAHASCAI 2005 Guideline Update for Percutaneous Coronary Intervention, Writing on Behalf of the 2005 Writing Committee.","volume":"117","author":"King","year":"2008","journal-title":"Circulation"},{"key":"R27-31-20210203","doi-asserted-by":"crossref","first-page":"600S","DOI":"10.1378\/chest.126.3_suppl.600S","article-title":"Antithrombotic therapy in patients with saphenous vein and internal mammary artery bypass grafts: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.","volume":"126","author":"Stein","year":"2004","journal-title":"Chest"},{"key":"R29-31-20210203","first-page":"1671","article-title":"Propensity scores: help or hype Nephrol Dial Transplant.","volume":"19","author":"Winkelmayer","year":"2004","journal-title":""},{"key":"R30-31-20210203","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ahj.2007.10.003","article-title":"ATACAS trial group. aspirin and tranexamic acid for coronary artery surgery (ATACAS) Trial: rationale and design.","volume":"155","author":"Myles","year":"2008","journal-title":"Am Heart J"},{"key":"R31-31-20210203","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jcin.2008.01.008","article-title":"Randomized clinical trials and observational studies: guidelines for assessing respective strengths and limitations.","volume":"1","author":"Hannan","year":"2008","journal-title":"JACC Cardiovasc Interv"},{"key":"R32-31-20210203","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1093\/bja\/aen377","article-title":"Antifibrinolytics in cardiac surgical patients receiving aspirin: a systematic review and meta-analysis.","volume":"102","author":"McIlroy","year":"2009","journal-title":"Br J Anaesth"},{"key":"R33-31-20210203","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1001\/jama.1991.03470010097038","article-title":"Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials.","volume":"266","author":"Yusuf","year":"1991","journal-title":"JAMA"}],"container-title":["Annals of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/SLA.0b013e318234313b","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:31:40Z","timestamp":1786048300000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000658-201202000-00031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/sla.0b013e318234313b","relation":{},"ISSN":["0003-4932"],"issn-type":[{"value":"0003-4932","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}